靶点针对疾病信息29(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Serine/threonine-protein kinase mTOR (mTOR)
INDICATI
Approved Arteries/arterioles disorder [ICD-11: BD52]
INDICATI
Approved Chronic myelomonocytic leukaemia [ICD-11: 2A40]
INDICATI
Approved Hydrocephalus [ICD-11: 8D64]
INDICATI
Approved Multiple myeloma [ICD-11: 2A83]
INDICATI
Phase 3 Sarcoma [ICD-11: 2A60-2C35]
INDICATI
Phase 2 Bladder cancer [ICD-11: 2C94]
INDICATI
Phase 2 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 2 Endometrial cancer [ICD-11: 2C76]
INDICATI
Phase 2 Head and neck cancer [ICD-11: 2D42]
INDICATI
Phase 2 Liver cancer [ICD-11: 2C12]
INDICATI
Phase 2 Lung cancer [ICD-11: 2C25]
INDICATI
Phase 2 Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Phase 2 Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y]
INDICATI
Phase 2 Metastatic lymph node neoplasm [ICD-11: 2D60]
INDICATI
Phase 2 Pain [ICD-11: MG30-MG3Z]